Aclaris Therapeutics's total assets for Q2 2025 were $189.15M, a decrease of -4.52% from the previous quarter. ACRS total liabilities were $57.41M for the fiscal quarter, a 6.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.